Hi-Clearance Inc. (TPEX:1788)

Market Cap	6.39B
Revenue (ttm)	4.16B
Net Income (ttm)	348.16M
Shares Out	44.52M
EPS (ttm)	7.81
PE Ratio	18.37
Forward PE	n/a
Dividend	7.00 (4.88%)
Ex-Dividend Date	Jun 14, 2024

Volume	16,091
Average Volume	10,260
Open	144.00
Previous Close	143.50
Day's Range	143.00 - 144.00
52-Week Range	130.00 - 147.00
Beta	0.18
RSI	54.07
Earnings Date	May 9, 2025

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and servi...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1989
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1788

Financial Performance

In 2024, Hi-Clearance's revenue was 4.07 billion, an increase of 4.54% compared to the previous year's 3.90 billion. Earnings were 359.69 million, an increase of 3.36%.